Hypertension (high pressure)

Most common fatal disease

Hypertension is known as a "silent killer": despite the fact that this disease is often asymptomatic, it can lead to serious disorders of the cardiovascular system.

Hypertension (AH), which, according to data for 2021, affects about 1.2 billion people in the world, is the most common fatal disease. About 10 million people die from high blood pressure in the world every year. According to forecasts, by 2025 this disease will be diagnosed in 29.2% of the adult population of the planet, which is 1.56 billion people.

In Russia, the prevalence of arterial hypertension, as of 2019, is 44.4% of the total population, that is, 65,170,639 people, and this figure is expected to ^[1]

Pulmonary hypertension

Main article: Pulmonary arterial hypertension

2024

The share of Russians with high blood pressure since 2019 has grown from 22% to 29.9 %

The number of Russians with diagnosed hypertension has increased significantly over the past five years. As of October 22, 2024, the proportion of identified patients with high blood pressure reached 29.9% of the total number of examined, while in 2019 this figure was 22%.

According to Kommersant, these statistics were announced by Yevgeny Shlyakhto, Director General of the V. Almazov National Medical Research Center, at a round table in the State Duma. In Russia, 32% of the adult population suffer from high blood pressure.

Since 2019, the share of Russians with high blood pressure has increased from 22% to 29.9%

The head of the State Duma Health Protection Committee Badma Bashankaev stressed that hypertension annually leads to 10 million premature deaths and about 200 million cases of disability in the world. Elevated pressure is a major risk factor for coronary heart disease, heart attacks and strokes.

Ramil Khabriev, scientific director of the Semashko National Research Institute of Public Health, cited data on the previously existing program to combat hypertension. Since 2001, the program has reduced the incidence of cerebrovascular diseases and coronary heart disease by 13-18%, disability - by 10-12%, mortality from strokes and heart attacks - by 10-16%. The prevented economic damage amounted to ₽22,4 billion.

Advisor to the Minister of Finance Vladimir Shalaev said that federal budget expenditures on drug supply in the outpatient sector by 2024 increased to ₽387,4 billion. In 2025, it is planned to allocate ₽435 billion for these purposes, in 2026 - ₽469,1 billion, in 2027 - ₽494,5 billion.

Tatyana Frolova, a member of the Duma Health Protection Committee, noted that patients with hypertension who have not suffered a heart attack or stroke should be provided with medicines at the expense of regional budgets, but the subjects do not have enough funds for these purposes.^[2]

Xiaomi has released a smartwatch that measures blood pressure

In mid-October 2024, Xiaomi introduced the Watch H1 E smartwatch with round-the-clock blood pressure monitoring. This feature will help prevent the risk of hypertension. Read more here.

Underwear capable of measuring blood pressure released

On January 4, 2024, Nanowear announced the release of the new Simplesense underwear, which is capable of measuring blood pressure with high accuracy. The data collected can be remotely analyzed by medical professionals to identify dangerous abnormalities. Read more here.

2023

Sales of blood pressure measuring devices in Russia for the year increased by 30%

At the end of 2023, approximately 6.1 million tonometers were sold in Russia. This is 30% more than the result for the previous year, when the market size was estimated at about 4.4 million units. Such data at the end of February 2024 are given in a study by RNC Pharma. Read more here.

Renal denervation system was released with minimal intervention in the patient's body for the treatment of hypertension

On December 19, 2023, Ablative Solutions announced the Peregrine System platform for the treatment of hypertension. This system allows renal denervation through a minimally invasive procedure, which reduces the risk of complications and shortens the rehabilitation period. Read more here.

Doctors start treating hypertension with Medtronic renal denervation system

On 28 Nov 2023, Symplicity Spyral reported that the first patient was successfully treated with the Symplicity Spyral renal denervation system. This multi-contact catheter with spiral construction is designed specifically for the treatment of hypertensive disease. Read more here.

Clinics have started using smart rings to continuously monitor blood pressure

On October 17, 2023, South Korean medical technology startup Sky Labs announced the release of a smart ring called CART BP for continuous blood pressure monitoring. This wearable device began to be used by hospitals and clinics across Korea. Read more here.

Presented a device attached to a smartphone for quick measurement of blood pressure

In mid-June 2023, engineers at the University of California, San Diego, unveiled a cuffless blood pressure meter. The device is a clip that attaches to the smartphone camera and flash. The user presses the finger against the clamp, and the system can determine the amount of blood passing through the finger and the force of pressure exerted by the finger on the clamp. The smartphone app then uses algorithms to interpret this data and assess blood pressure. As of June 16, 2023, the cost of the clip is only $0.8, allowing people in low-resource areas to control their blood pressure. In mass production, the clip could cost as little as $0.1, the researchers say. Read more here.

Mobile Phone Conversations Increase 12% Risk of Hypertension

On May 4, 2023, Chinese specialists from Southern Medical University in Guangzhou presented the results of a study stating that mobile phone communication significantly increases the risk of hypertension - a chronically occurring disease accompanied by high blood pressure. Read more here.

Developed a blood pressure sensor for smartwatches with the accuracy of medical devices

In mid-April 2023, a research team from the Catholic University of Korea and the Korea Institute for Advanced Technology (KAIST) unveiled a highly sensitive wearable piezoelectric blood pressure sensor that the developer claims works with the accuracy of medical devices. Read more here.

Ultrasound catheter for the treatment of hypertension presented

In the first half of March 2023, it became known that specialists from the Irving Medical Center at Columbia University and researchers from the University of Paris successfully tested a catheter for the treatment of hypertension. Read more here.

European Community of Cardiology recommends kidney denervation to treat blood pressure

At the end of February 2023, it became known that patients whose high blood pressure remains despite taking drugs and changing their lifestyle can be treated with renal denervation. The relevant recommendation was made by the European Community of Cardiology.

Renal denervation is a minimally invasive procedure that uses a radiofrequency or ultrasound device on a catheter to remove nerves in the renal artery. Early in 2022, the threat of failed clinical trials loomed over the procedure, but results from later randomized controlled trials point to safety.

Based on these results, a panel of EU experts recommended renal denervation, as a treatment method as an alternative for patients whose high blood pressure does not lend itself to lifestyle changes and taking a combination of three drugs for pressure. This is also an acceptable option for patients who cannot tolerate long-term therapy with antihypertensive drugs. According to a consensus statement, it can be used as an earlier intervention if patients express a strong preference for kidney denervation after intensive consultation with a doctor.

In a review of the results, European experts noted no particular safety concerns other than radiation and a potential complication associated with an artery access procedure that occurred in less than 1% of cases. In the long term, patients may develop artery stenosis associated with vascular damage and impaired kidney function, according to the study, the results of which were published in the European Heart Journal.

A consensus statement should support the insurance coverage of this procedure in Europe. Medtronic's Simplicity Spyral renal denervation system has had a CE Mark since 2013, but insurance coverage has been problematic as it has been recommended in the past for use only in clinical trial settings. In the US, Medtronic submitted the results of the SPYRAL HTN-ON MED study to the FDA, hoping to win approval in 2023.^[3]

2022

A video camera has been developed that determines blood pressure in the face

On December 5, 2022, the University of South Australia (UniSA) announced the development of an innovative system to measure a patient's blood pressure using a camera. Read more here.

State project for remote monitoring of blood pressure launched in Novgorod region

A state project for remote monitoring of blood pressure has been launched in the Novgorod region. At first, 10 thousand people will take part in it. Read more here.

Russia's largest remote monitoring project for patients with chronic diseases launched in Udmurtia

The largest project in Russia for remote monitoring of patients with chronic diseases has been launched in Udmurtia. As the press service of the head and government of the region reported on October 3, 2022, it is being implemented jointly with the SberZdorovye service. Read more here.

Servier introduced a combined drug for the treatment of arterial hypertension and dyslipidemia

Servier presented on September 30, 2022 the drug Lipertans (amlodipine + atorvastatin + perindopril) for the treatment of arterial hypertension and dyslipidemia. The drug product in a dosage of 5 mg + 10 mg + 5 mg is already available to Russian patients. Lipertance in dosages of 5 mg + 20 mg + 5 mg and 5 mg + 20 mg + 10 mg will appear in Russian pharmacies by the end of October 2022 . Read more here.

Implant released to lower blood pressure in patients with pacemakers

At the end of September 2022, the BackBeat blood pressure lowering implant was released. This is a development by Orchestra BioMed. Read more here.

Garmin has released its first blood pressure monitor. It is wireless and connects to a smartphone

In September 2022, Garmin launched the first monitor in its range to measure systolic and diastolic blood pressure. The device works remotely. Read more here.

"Daughter" "Rostec" was chosen by the operator of the legal regime for remote monitoring of patients with diabetes and hypertension

"Daughter" "Rostec was chosen by the operator of the experimental legal regime (EPR) for remote monitoring of patients with diabetes and hypertension. This became known in early September 2022 from the relevant document. Ministry of Economic Development More. here

Scientists have proposed a method for early diagnosis of hypertension using a solution of silver nanoparticles

Russian scientists have proposed a methodology for diagnosing hypertension in the early stages. It is based on the use of silver nanostructures, which make it possible to increase the sensitivity of the study using surface-enhanced Raman spectroscopy. The proposed method allows detecting early hypertensive changes in blood cells and starting treatment in time. The study is published in the journal Biosensors. This was announced by NUST MISIS on July 15, 2022. Read more here.

At Elizabethan Hospital, patient blood pressure data are automatically transferred to IT systems

As it became known in May 2022, in the Elizabethan hospital, data on the blood pressure of patients are automatically transferred to the IT system. The latter is called the Unified Medical Information System for Remote Monitoring of Blood Pressure (ESAD). Read more here.

Walking robot released to measure blood pressure by touching man

On February 23, 2022, researchers at Simon Fraser University in Canada unveiled a humanoid robot that can measure blood pressure by touching a patient's chest. The robot uses sensors at the fingertips to measure. Read more here.

RDIF invests in drug developer to treat hypertension

On February 1, 2022, an investment in Target Medicines was announced. The developer of the drug for the treatment of hypertension has invested the Russian Direct Investment Fund (RDIF), pharmaceutical giant AstraZeneca and Unicorn Capital Partners (the management company of the venture capital fund PharmMed Innovations). Read more here.

2021

KRET introduced a magnetotherapeutic chair for the treatment of hypertension

In December 2021, the Kasimov Instrument Plant, part of the Concern Radioelectronic Technologies (KRET), presented the RelaxationMagh magnetotherapeutic chair for the treatment of heart disease, including hypertension. Read more here.

Announcement of the device for measuring blood pressure 24/7

On September 29, 2021, the VitalStream continuous non-invasive blood pressure and hemodynamics monitoring device from Caretaker Medical was released. Read more here.

ECG and pressure measurement functions in Samsung smartwatches are available in Russia

ECG and pressure measurement functions on Samsung Health Monitor smartwatches have become available in Russia. Samsung Electronics announced this at the end of April 2021. Read more here.

Announcement of Aktiia - bracelet for blood pressure measurement

At the end of January 2021, the Swiss company Aktiia released a bracelet for manga-free blood pressure monitoring, which became available in the US and European markets. Read more here.

2018

The world's first pressure watch is presented

In late December 2018, Omron Healthcare released what the company claims is the world's first HeartGuide blood pressure watch. Read more here.

Increase in the number of new cases of hypertension by 57%

On December 9, 2019, it became known about a 57 percent increase in the number of new cases of hypertension in Russia. The data is provided by Rosstat.

If in 2008 979 thousand patients with high blood pressure in the Russian Federation were identified, then in 2018 there were already 1.54 million of them. These values ​ ​ reflect the number of newly detected cases of diagnosis of "hypertension," said Sergey Boytsov, chief freelance specialist of the Ministry of Health in cardiology. So, in Russia there is an increase in the detection of this disease.

According to Boytsov, only among men under the age of 65 years, the incidence of arterial hypertension is 49%, and in women - 40%. At the same time, about 42% of men and about 62% of women take drugs to reduce blood pressure, so the task of identifying patients with hypertension is one of the most important in the framework of medical examination and preventive medical examinations of the adult population, he added.

In Russia, until 2024, the national project "Healthcare" will be implemented, on which it is planned to spend more than 1.7 trillion rubles. The project, in particular, involves work to reduce mortality from cardiovascular diseases and re-equipping 140 vascular centers and 469 primary vascular departments with modern medical equipment.^[4]

Renal denervation surgery was performed for the first time at the National Medical Research Center of Cardiology

For the first time in the Central Federal District RUSSIAN FEDERATION , on October 16, 2018, operations were performed to treat hypertension by the method. renervation Operations were performed "National Medical Research Center of Cardiology" at the National Medical Research Center of Cardiology Ministry of Health Russia using an innovative catheter Symplicity Spyral manufactured by the company. Medtronic More. here

In Russia, for the first time, the method of renal denervation was used to treat AH

For the first time in Russia, the Research Institute of Cardiology of the Tomsk Research Institute of Medical Sciences performed operations to treat hypertension by the method of renal denervation using the innovative Symplicity Spyral catheter developed by Medtronic. This was reported on July 6, 2018 in Medtronic Russia. Read more here.

Asus unveils smartwatch with real-time blood pressure monitoring

On June 5, 2018, Asus showed off the VivoWatch BP smartwatch (model number HC-A04), equipped with real-time blood pressure monitoring. Read more here.

2017: Effectiveness of renal denervation

In late August 2017, Medtronic presented the results of the company-sponsored SPYRAL HTN-OFF MED study on the efficacy of renal (renal) denervation. Read more here.

Notes